{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:25:50Z","timestamp":1791141950085,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.autrev.2014.01.040","type":"journal-article","created":{"date-parts":[[2014,1,11]],"date-time":"2014-01-11T10:45:29Z","timestamp":1389437129000},"page":"445-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Diagnosis and classification of primary sclerosing cholangitis"],"prefix":"10.1016","volume":"13","author":[{"given":"Kidist K.","family":"Yimam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.01.040_bb0005","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199504063321406","article-title":"Primary sclerosing cholangitis","volume":"332","author":"Lee","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2014.01.040_bb0010","unstructured":"Feldman: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 9th Ed."},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2014.01.040_bb0015","doi-asserted-by":"crossref","first-page":"S470","DOI":"10.1111\/j.1872-034X.2007.00241.x","article-title":"Characteristics of primary sclerosing cholangitis in Japan","volume":"37","author":"Takikawa","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.autrev.2014.01.040_bb0020","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.040_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer","volume":"26","author":"Broom\u00e9","year":"2006","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.040_bb0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.autrev.2014.01.040_bb0035","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(94)80240-8","article-title":"Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver","volume":"21","author":"Escorsell","year":"1994","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.autrev.2014.01.040_bb0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1440-1746.1996.tb00286.x","article-title":"Primary sclerosing cholangitis: an experience from India","volume":"11","author":"Kochhar","year":"1996","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.01.040_bb0045","first-page":"685","article-title":"Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group","volume":"8","author":"Okolicsanyi","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.040_bb0050","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.040_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.autrev.2014.01.040_bb0060","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.autrev.2014.01.040_bb0065","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2004.04.052","article-title":"Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom","volume":"126","author":"Kingham","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0070","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.autrev.2014.01.040_bb0075","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2008.02.017","article-title":"Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study","volume":"48","author":"Card","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2014.01.040_bb0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-230X-11-83","article-title":"The prevalence, incidence and natural history of primary sclerosin cholangitis in an ethnically diverse population","volume":"11","author":"Toy","year":"2011","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"10.1016\/j.autrev.2014.01.040_bb0085","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/lt.22161","article-title":"Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations","volume":"16","author":"Bowlus","year":"2010","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.040_bb0090","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broom\u00e9","year":"1996","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1089-3261(05)70008-8","article-title":"Clinical features in primary sclerosing cholangitis","volume":"2","author":"Bergquist","year":"1998","journal-title":"Clin Liver Dis"},{"issue":"21","key":"10.1016\/j.autrev.2014.01.040_bb0100","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.3748\/wjg.14.3338","article-title":"Clinical features and management of primary sclerosing cholangitis","volume":"14","author":"Silveira","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0105","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.040_bb0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00054725-200501000-00009","article-title":"Primary sclerosing cholangitis","volume":"11","author":"Talwalkar","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2014.01.040_bb0115","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.autrev.2014.01.040_bb0120","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.autrev.2014.01.040_bb0125","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/gut.33.10.1370","article-title":"Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique","volume":"33","author":"Lo","year":"1992","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.040_bb0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.040_bb0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/PAS.0b013e3181c6c09a","article-title":"IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis","volume":"34","author":"Zhang","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.040_bb0145","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e3181c9dac6","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy","volume":"18","author":"Bj\u00f6rnsson","year":"2011","journal-title":"Am J Ther"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.040_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11894-006-0067-8","article-title":"Primary sclerosing cholangitis: diagnosis and management","volume":"8","author":"Charatcharoenwitthaya","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.autrev.2014.01.040_bb0160","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/s-2008-1077509","article-title":"Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis","volume":"40","author":"Weber","year":"2008","journal-title":"Endoscopy"},{"issue":"13","key":"10.1016\/j.autrev.2014.01.040_bb0165","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM199609263351301","article-title":"Complications of endoscopic biliary sphincterotomy","volume":"335","author":"Freeman","year":"1996","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.040_bb0170","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0016-5085(76)80139-4","article-title":"Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases","volume":"70","author":"Bilbao","year":"1976","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.autrev.2014.01.040_bb0175","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.autrev.2014.01.040_bb0185","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.1840010612","article-title":"Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis","volume":"1","author":"Ludwig","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.040_bb0190","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.autrev.2014.01.040_bb0195","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: a long-term follow-up study","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.040_bb0200","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.040_bb0205","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis","volume":"33","author":"Van Buuren","year":"2000","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.autrev.2014.01.040_bb0210","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","article-title":"Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients","volume":"38","author":"Boberg","year":"2003","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.autrev.2014.01.040_bb0215","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.21685","article-title":"Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature","volume":"45","author":"Bj\u00f6rnsson","year":"2007","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.autrev.2014.01.040_bb0220","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/01.mcg.0000180629.77066.6c","article-title":"Extrapancreatic lesions in autoimmune pancreatitis","volume":"39","author":"Kamisawa","year":"2005","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"10.1016\/j.autrev.2014.01.040_bb0225","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/01.pas.0000136449.37936.6c","article-title":"IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?","volume":"28","author":"Zen","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.autrev.2014.01.040_bb0230","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.autrev.2014.01.040_bb0235","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.040_bb0240","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.autrev.2014.01.040_bb0245","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0250","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.autrev.2014.01.040_bb0255","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2014.01.040_bb0260","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1399-0039.1999.530502.x","article-title":"HLA class II haplotype in primary sclerosing cholangitis patients from five European populations","volume":"53","author":"Spurkland","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2014.01.040_bb0265","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.1840160217","article-title":"Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis","volume":"16","author":"Farrant","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.040_bb0270","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0016-5085(94)95085-7","article-title":"HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis","volume":"106","author":"Mehal","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2014.01.040_bb0275","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0016-5085(95)90463-8","article-title":"HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis","volume":"108","author":"Olerup","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2014.01.040_bb0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-933559","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"26","author":"O'Mahony","year":"2006","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.040_bb0285","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1172\/JCI115996","article-title":"Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth","volume":"90","author":"Lichtman","year":"1992","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.040_bb0290","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/hep.1840380428","article-title":"Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions","volume":"38","author":"Wu","year":"2003","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.autrev.2014.01.040_bb0295","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.3748\/wjg.14.3350","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"14","author":"Chapman","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"9301","key":"10.1016\/j.autrev.2014.01.040_bb0300","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.040_bb0305","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.040_bb0310","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00439-003-0963-z","article-title":"Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis","volume":"113","author":"Sheth","year":"2003","journal-title":"Hum Genet"},{"issue":"10","key":"10.1016\/j.autrev.2014.01.040_bb0315","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.autrev.2014.01.040_bb0320","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.040_bb0325","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0330","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.autrev.2014.01.040_bb0335","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1572-0241.2000.02323.x","article-title":"Oral budesonide in the treatment of primary sclerosing cholangitis","volume":"95","author":"Angulo","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0340","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0016-5085(94)90610-6","article-title":"A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis","volume":"106","author":"Knox","year":"1994","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.040_bb0345","first-page":"511","article-title":"Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study","volume":"91","author":"Lindor","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.autrev.2014.01.040_bb0350","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2036.2004.02214.x","article-title":"A prospective, randomized\u2013controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis","volume":"20","author":"Sterling","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0355","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1572-0241.2005.40484.x","article-title":"Mycophenolate mofetil for the treatment of primary sclerosing cholangitis","volume":"100","author":"Talwalkar","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.040_bb0360","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1478-3231.2007.01441.x","article-title":"Tacrolimus for the treatment of primary sclerosing cholangitis","volume":"27","author":"Talwalkar","year":"2007","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.autrev.2014.01.040_bb0365","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1572-0241.2000.02324.x","article-title":"A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis","volume":"95","author":"Bharucha","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.040_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:DDAS.0000011827.87103.2e","article-title":"A pilot study of etanercept in the treatment of primary sclerosing cholangitis","volume":"49","author":"Epstein","year":"2004","journal-title":"Dig Dis Sci"},{"issue":"supplement 1","key":"10.1016\/j.autrev.2014.01.040_bb0375","doi-asserted-by":"crossref","first-page":"S532","DOI":"10.1016\/S0168-8278(13)61319-7","article-title":"Simtuzumab, an antifibrotic monoclonal antibody against lysyl oxidase-like 2 (LOXL2) enzyme, appears safe and well tolerated in patients with liver disease of diverse etiology","volume":"58","author":"Talal","year":"2013","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.040_bb0380","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ajg.2008.14","article-title":"Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study","volume":"104","author":"Silveira","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.autrev.2014.01.040_bb0385","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","volume":"40","author":"F\u00e4rkkil\u00e4","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.040_bb0390","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0b013e31816fee95","article-title":"Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic","volume":"47","author":"Davies","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.autrev.2014.01.040_bb0395","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.12232","article-title":"Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis \u2014 a pilot study","volume":"37","author":"Tabibian","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0400","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0405","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.040_bb0410","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.040_bb0415","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1478-3231.2006.01395.x","article-title":"Recurrence of primary sclerosing cholangitis after living donor liver transplantation","volume":"27","author":"Tamura","year":"2007","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.040_bb0420","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.transproceed.2005.12.026","article-title":"Recurrence of primary sclerosing cholangitis in patients after liver transplantation","volume":"38","author":"O\u0142dakowska-Jedynak","year":"2006","journal-title":"Transplant Proc"},{"issue":"11","key":"10.1016\/j.autrev.2014.01.040_bb0425","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.20444","article-title":"Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors","volume":"11","author":"Brandsaeter","year":"2005","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.autrev.2014.01.040_bb0430","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1053\/jlts.2002.33952","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation","volume":"8","author":"Graziadei","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.autrev.2014.01.040_bb0435","article-title":"Novel insights into autoimmune liver diseases provided by genome-wide association studies","author":"Mells","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.01.040_bb0440","article-title":"Mucosal immunity in liver autoimmunity: a comprehensive review","author":"Trivedi","year":"2014","journal-title":"J Autoimmun"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T07:11:48Z","timestamp":1565075508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":88,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1568997214000524"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.01.040","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and classification of primary sclerosing cholangitis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}